NovoSeven RT (coagulation factor viia) Disease Interactions
There is 1 disease interaction with NovoSeven RT (coagulation factor viia):
Coagulation factor VIIa (Includes NovoSeven RT) ↔ thrombosis
Severe Potential Hazard, Moderate plausibility. Applies to: Thrombotic/Thromboembolic Disorder
Serious arterial and venous thrombotic events have been reported with the use of coagulation factor VIIa. Patients at an increased risk of thromboembolic complications may include those with a history of coronary heart disease, liver disease, disseminated intravascular coagulation, post-operative immobilizations, elderly patients, and neonates. It is recommended to exercise caution when administering coagulation factor VIIa to patients at risk and the potential benefit of treatment should be weighed against the risk of these complications.
NovoSeven RT (coagulation factor viia) drug interactions
There are 5 drug interactions with NovoSeven RT (coagulation factor viia)
More about NovoSeven RT (coagulation factor viia)
- NovoSeven RT Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- Drug class: miscellaneous coagulation modifiers
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.